Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$795
in 4 filings, $795 under 10b5-1 plans

Net −$795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-22 Ausiello Dennis A Director Grant or award · Stock Option (right to buy) +35,000 35,000
2023-06-22 Berenson Stephen Director Grant or award · Stock Option (right to buy) +35,000 35,000
2023-06-22 Fraser Claire Director Grant or award · Stock Option (right to buy) +35,000 35,000
2023-06-22 Behar Gregory Director Grant or award · Stock Option (right to buy) +35,000 35,000
2023-06-22 Graves Kurt Director Grant or award · Stock Option (right to buy) +35,000 35,000
2023-06-22 Kender Richard N Director Grant or award · Stock Option (right to buy) +35,000 35,000
2023-06-22 Dere Willard H Director Grant or award · Stock Option (right to buy) +35,000 35,000
2023-04-28 Ege David S. Sale −7,038 $5.19 $37K 59,696
2023-04-27 Cloghessy Paula Grant or award · Restricted Stock Units 10b5-1 +18,835 18,835
2023-04-27 Shaff Eric D. CEO and President Grant or award · Restricted Stock Units 10b5-1 +55,675 55,675
2023-04-27 Young Teresa L. Grant or award · Restricted Stock Units 10b5-1 +22,721 22,721
2023-04-27 Arkowitz David Chief Financial Officer Grant or award · Restricted Stock Units 10b5-1 +26,418 26,418
2023-04-27 DesRosier Thomas Chief Legal Officer and EVP Grant or award · Restricted Stock Units 10b5-1 +27,001 27,001
2023-04-27 Ege David S. Grant or award · Restricted Stock Units 10b5-1 +22,721 22,721
2023-04-27 von Moltke Lisa Grant or award · Restricted Stock Units 10b5-1 +27,489 27,489
2023-04-27 Henn Matthew R. Grant or award · Restricted Stock Units 10b5-1 +25,245 25,245
2023-04-27 Ege David S. Grant or award +20,000 66,734
2023-04-27 Arkowitz David Chief Financial Officer Grant or award +42,500 166,613
2023-04-27 Henn Matthew R. Grant or award · Stock Option (Right to Buy) +35,000 70,000
2023-02-03 Ege David S. Grant or award · Restricted Stock Units +47,500 47,500

Page 18 of 23 · 458 trades